This compound is primarily used in the synthesis of pharmaceutical intermediates, particularly in the development of drugs targeting neurological and cardiovascular diseases. Its structure, featuring a pyrrolidine ring and a hydroxymethyl group, makes it a valuable building block for creating bioactive molecules. It is often employed in peptide synthesis and as a chiral auxiliary in asymmetric synthesis, aiding in the production of enantiomerically pure compounds. Additionally, it plays a role in the design of enzyme inhibitors and receptor modulators, contributing to advancements in medicinal chemistry. Its stability and reactivity also make it suitable for use in organic transformations and as a protective group in multi-step synthetic processes.